Siemens has bought manufacturing execution systems (MES) software supplier, Elan Software Systems SA, in a bid to expand its industrial portfolio in the pharmaceutical and biotech industries.
Based in Toulouse, France, Elan is an international software supplier for MES in the pharmaceutical and biotech industries.
Siemens’ acquisition will allow its Industry Automation Division to extend its global presence in the market for industrial software.
Agreement was reached not to disclose the purchase price, according to Siemens. In 2007, the same division absorbed UGS in the USA and in 2008 Innotec in Germany. Like Elan, both companies also offer industrial software in dedicated fields.
“Particularly for the pharmaceutical and biotech industries, the Elan product range ideally supplements our Simatic IT MES portfolio, which is itself already a leader in its field. Elan has excellent manufacturing process know-how in these industries, where it has been a recognised partner and preferred software supplier to many well-known companies for twenty years. On this foundation we intend to build our worldwide MES software business in these industries”, said the Elan Business Unit CEO, Ralf-Michael Franke.
According to Franke, Elan’s business activities ideally complement the Siemens process industry portfolio, such as the Simatic IT MES portfolio, the process control system PCS 7 and the Comos lifecycle management systems added in 2008 by the acquisition of Innotec.
“We will be continuing our successful strategy. Our customers can go on counting on our outstanding range of products and services and also rely on a strong partner under the Siemens roof who can offer them security of investment “, said Elan Software Systems SA managing director, Jean-Pierre Amadio.